ARG1 and neoplasm: In vitro treatment of macrophage cell lines with a P2Y12 antagonist increased tumor cell phagocytosis and increased the expression of the anti-tumoral macrophage marker HLA-DR, while simultaneously reducing the expression of the pro-tumoral macrophage marker arginase-1.